.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
UBS
Dow
US Army
McKinsey
AstraZeneca
QuintilesIMS
Boehringer Ingelheim
Fuji
Accenture

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077029

« Back to Dashboard

NDA 077029 describes CALCIPOTRIENE, which is a drug marketed by Glenmark Pharms, Tolmar, Glenmark Pharms Inc, Fougera Pharms, G And W Labs Inc, Hi Tech Pharma, and Perrigo Israel, and is included in nine NDAs. It is available from eight suppliers. Additional details are available on the CALCIPOTRIENE profile page.

The generic ingredient in CALCIPOTRIENE is betamethasone dipropionate; calcipotriene hydrate. There are sixty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene hydrate profile page.

Summary for 077029

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Dermatological Agents

Pharmacology for NDA: 077029

Ingredient-typeVitamin D

Suppliers and Packaging for NDA: 077029

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CALCIPOTRIENE calcipotriene SOLUTION;TOPICAL 077029 ANDA Impax Generics 0115-1475 0115-1475-55 60 mL in 1 BOTTLE, DROPPER (0115-1475-55)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;TOPICALStrength0.005%
Approval Date:Nov 20, 2009TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Fish and Richardson
Fuji
Federal Trade Commission
Julphar
Argus Health
Johnson and Johnson
Express Scripts
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot